Serial Number | 75933717 |
Word Mark | PROFLUEN |
Filing Date | Thursday, March 2, 2000 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Saturday, September 7, 2002 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, December 12, 2000 |
Goods and Services | anti-infective pharmaceutical |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, May 25, 2000 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | BIOCRYST PHARMACEUTICALS, INC. |
Party Type | 21 - New Owner After Publication |
Legal Entity Type | 03 - Corporation |
Address | NEW BRUNSWICK, NJ 089337001 |
Party Name | JOHNSON & JOHNSON |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | New Brunswick, NJ 089337001 |
Party Name | JOHNSON & JOHNSON |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | New Brunswick, NJ 089337001 |
Event Date | Event Description |
Saturday, June 7, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
Wednesday, March 6, 2002 | EXTENSION 2 GRANTED |
Monday, February 11, 2002 | EXTENSION 2 FILED |
Monday, June 18, 2001 | EXTENSION 1 GRANTED |
Monday, March 19, 2001 | EXTENSION 1 FILED |
Tuesday, March 6, 2001 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, December 12, 2000 | PUBLISHED FOR OPPOSITION |
Friday, November 10, 2000 | NOTICE OF PUBLICATION |
Thursday, August 10, 2000 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, August 7, 2000 | ASSIGNED TO EXAMINER |